Moran Wealth Management LLC Takes Position in Smith & Nephew plc (NYSE:SNN)

Moran Wealth Management LLC bought a new stake in Smith & Nephew plc (NYSE:SNN - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 189,642 shares of the medical equipment provider's stock, valued at approximately $5,173,000.

Other large investors have also modified their holdings of the company. CWM LLC boosted its holdings in shares of Smith & Nephew by 68.6% in the 4th quarter. CWM LLC now owns 954 shares of the medical equipment provider's stock valued at $26,000 after buying an additional 388 shares in the last quarter. Spire Wealth Management boosted its holdings in shares of Smith & Nephew by 224.3% in the 4th quarter. Spire Wealth Management now owns 1,015 shares of the medical equipment provider's stock valued at $29,000 after buying an additional 702 shares in the last quarter. Allworth Financial LP boosted its stake in Smith & Nephew by 1,566.2% during the 3rd quarter. Allworth Financial LP now owns 1,133 shares of the medical equipment provider's stock worth $28,000 after purchasing an additional 1,065 shares during the period. GAMMA Investing LLC acquired a new stake in Smith & Nephew during the 4th quarter worth $53,000. Finally, Principal Securities Inc. acquired a new stake in Smith & Nephew during the 4th quarter worth $52,000. Institutional investors and hedge funds own 25.64% of the company's stock.

Analyst Upgrades and Downgrades

Separately, StockNews.com cut shares of Smith & Nephew from a "strong-buy" rating to a "buy" rating in a research note on Monday. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy".

Smith & Nephew Price Performance

NYSE:SNN traded down $0.06 during trading hours on Wednesday, reaching $25.71. 874,140 shares of the company's stock were exchanged, compared to its average volume of 1,001,210. The company has a 50-day moving average of $25.31 and a 200 day moving average of $26.21. The company has a quick ratio of 0.72, a current ratio of 1.77 and a debt-to-equity ratio of 0.44. Smith & Nephew plc has a 1-year low of $21.52 and a 1-year high of $32.71.

Smith & Nephew Announces Dividend

The company also recently announced a semi-annual dividend, which will be paid on Wednesday, May 22nd. Stockholders of record on Tuesday, April 2nd will be paid a $0.462 dividend. This represents a dividend yield of 2.8%. The ex-dividend date of this dividend is Monday, April 1st.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.